[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360433-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360433-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","predicting-muscle-invasive-bladder-cancer-with-dual-layer-detector-spectral-ct-derived-extracellular-volume-fraction-research-open-access","Predicting muscle-invasive bladder cancer with dual-layer detector spectral CT-derived extracellular volume fraction - Research Open Access","","Objectives evaluate the diagnostic performance of dual-layer detector spectral CT (DLCT)-derived extracellular volume fraction (ECV) for pre-operatively distinguishing muscle-invasive bladder cancer (MIBC) from non-muscle-invasive bladder cancer (NMIBC). Materials and methods: a retrospective cohort of 116 pathologically confirmed urothelial carcinoma patients underwent preoperative DLCT; reference classification used transurethral resection or cystectomy pathology. Measurements combined radiologists’ morphological and spectral CT parameters with univariate comparisons, multivariable logistic regression, and ROC analysis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/predicting-muscle-invasive-bladder-cancer-with-dual-layer-detector-spectral-ct-derived-extracellular-volume-fraction-research-open-access/360433/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/predicting-muscle-invasive-bladder-cancer-with-dual-layer-detector-spectral-ct-derived-extracellular-volume-fraction-research-open-access/360433.png","ImageObject",300,407,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What imaging metric does the study evaluate for predicting muscle-invasive bladder cancer?","Question",{"text":63,"@type":64},"The study evaluates DLCT-derived extracellular volume fraction (ECV) as a quantitative biomarker to distinguish MIBC from NMIBC pre-operatively.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients classified as MIBC or NMIBC in the study?",{"text":68,"@type":64},"Patients were classified based on pathological results from transurethral resection or cystectomy, serving as the reference standard.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were identified as independent predictors for MIBC?",{"text":72,"@type":64},"Multivariable analysis identified longest tumor contact length (CL) ≥ 3 cm and ECV as independent predictors for MIBC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360433,1790211898,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Lv etal. BMC Medical Imaging (2026) 26:290 [https://doi.org/10.1186/s12880-026-02342-y](https://doi.org/10.1186/s12880-026-02342-y)  \nBMC Medical Imaging  \nRESEARCH Open Access  \nPredicting muscle-invasive bladder cancer with dual-layer detector spectral CT-derived extracellular volume fraction  \nJian Lv1†, Pianpian Yang2†, Wei Zheng1†, Danyi Huang1, Yuling Feng1, Bingqin Huang1,3, Ronghua Mu1, Siyu Dai 1,3, Peijia Li1, Peng Yang1, Xin Li1, Xiqi Zhu4,5* and Xiaoyan Qin1*  \nAbstract  \nObjectives To evaluate the diagnostic performance of dual-layer detector spectral CT (DLCT)-derived extracellular volume fraction (ECV) for pre-operatively distinguishing muscle-invasive bladder cancer (MIBC) from non-muscleinvasive bladder cancer (NMIBC) .  \nMaterials and methods This retrospective study included 116 patients with pathologically confirmed urothelial carcinoma who underwent preoperative DLCT. Pathological results from transurethral resection or cystectomy served as the reference standard, classifying patients into MIBC (n = 57) and NMIBC (n = 59) groups. Two radiologists independently measured morphological features and spectral CT parameters, including iodine density and ECV. Statistical analyses involved univariate comparisons, multivariable logistic regression, and receiver operating characteristic (ROC) analysis.  \nResults Multivariable analysis identified the longest tumor contact length (CL) ≥ 3 cm (Odds Ratio [OR] = 5 . 827; p = 0 . 006) and ECV (OR = 1.378 per 1% increment; p \u003C 0. 001) as independent predictors of MIBC. The area under the ROC curve (AUC) for ECV (0 . 886) was significantly superior to that of CL ≥ 3 cm (0 . 726) (DeLong test, p = 0 . 040) . A combined model (ECV + CL) achieved an AUC of 0 . 869, which was not significantly better than ECV alone (p = 0 . 146) .  \nAt the optimal cut-off of 72 . 3%, ECV predicted MIBC with 84 . 2% sensitivity and 88. 1% specificity. Excellent inter-reader agreement was observed for all quantitative measurements (ICC ≥0. 86) .  \nConclusion DLCT-derived ECV is a robust, non-invasive, and reproducible quantitative biomarker that outperforms conventional morphological assessment for the pre-operative prediction of MIBC, offering significant potential for improving clinical decision-making and personalized treatment planning.  \n\n| †Jian Lv, PianpianYang and Wei Zheng contributed equally to this work. |\n| --- |\n| This paper has not been presented anywhere, and is not being considered for publication elsewhere. |\n\n*Correspondence: Xiqi Zhu  \n[xiqi.zhu@163.com](xiqi.zhu@163.com); [xiqi.zhu@ymun.edu.cn](xiqi.zhu@ymun.edu.cn)  \nXiaoyan Qin  \n[qinxiaoyan2013@163.com](qinxiaoyan2013@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLv et al. BMC Medical Imaging (2026) 26:290 Page 2 of 11  \nKeywords Bladder cancer, Muscle invasion,","cbCaikPecKRFMavw","https://ap.wps.com/l/cbCaikPecKRFMavw","pdf",2811225,11,"English","# Abstract\n# Objectives\n# Materials and methods\n# Results\n## Independent predictors\n## Diagnostic performance\n# Conclusion\n# Introduction\n## Clinical significance of MIBC vs NMIBC\n## Limitations of current diagnostic methods","[{\"question\":\"What imaging metric does the study evaluate for predicting muscle-invasive bladder cancer?\",\"answer\":\"The study evaluates DLCT-derived extracellular volume fraction (ECV) as a quantitative biomarker to distinguish MIBC from NMIBC pre-operatively.\"},{\"question\":\"How were patients classified as MIBC or NMIBC in the study?\",\"answer\":\"Patients were classified based on pathological results from transurethral resection or cystectomy, serving as the reference standard.\"},{\"question\":\"Which factors were identified as independent predictors for MIBC?\",\"answer\":\"Multivariable analysis identified longest tumor contact length (CL) ≥ 3 cm and ECV as independent predictors for MIBC.\"}]","Predicting muscle-invasive bladder cancer with dual-layer detector spectral CT-derived extracellular volume fraction - Research Open Access | PDF",1790140097,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67c03a174b0698085185ba5212625a93.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05e97d106a81b5da7b0269a830576d60.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83fffffc63db391b94007f3f614d8e05.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1ab788362e8740241a1eb73dcdca36e.webp",980,1306]